Biotickr logobiotickr

Bristol-Myers Squibb Co.

The 0R1F-LN stock trades on London Stock Exchange
united states of americaoncologytherapeuticsmultiple myelomasolid tumorslarge-caplung cancerhematologic malignancieslymphomaliver cancer

Company Description

The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.

Drug Pipeline

Source: Bristol-Myers Squibb Co. - 20220903
Asset
Indication
Phase
ABECMA
Multiple Myeloma
Phase 3
 
 
 
 
 
ipilimumab
Solid Tumors
Phase 1
 
 
 
 
 
nivolumab
Hematologic Malignancies
Phase 1
 
 
 
 
 
Liver Cancer
Phase 3
 
 
 
 
 
Lung Cancer
Phase 3
 
 
 
 
 
Solid Tumors
Phase 2
 
 
 
 
 
romidepsin
Lymphoma
Phase 3
 
 
 
 
 

Conversation

0 following
Messages Image
Log in or sign up to join the conversation.
LoginSign up

0 Comments on 0R1F-LN stock

Newest

Relevant Publications

beta

The contributions of deleterious rare alleles in NLRP12 and inflammasome-related genes to polymyalgia rheumatica

Human leucocyte antigens and Japanese patients with polymyalgia rheumatica: the protective effect of DRB1*09:01

Long-term effects of abatacept on atherosclerosis and arthritis in older vs. younger patients with rheumatoid arthritis: 3-year re...

Nivolumab plus relatlimab in patients with previously treated microsatellite instability-high/mismatch repair-deficient metastatic...

Treatment rationale and protocol design: an investigator-initiated phase II study of combination treatment of nivolumab and TM5614...